🦠🤖 Ēvolvere Biosciences (YC S24) uses computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells.
Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria an exponentially growing global health crisis which is undermining modern medicine: it already kills more people than malaria and AIDS.
Evolvere creates protein-protein interaction datasets combined with foundation models of evolution to forecast bacterial mutations and create ‘future-proof’ antibiotics - addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients.
Founded by a team of biochemists and evolutionary biologists from the University of Oxford, Piotr Jedryszek, Weronika Ślesak, and Adam Winnifrith are on a mission to make the next-generation of antibiotics.
Congrats to the team on the launch!
🚀 https://lnkd.in/durfbEqv